Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma-Reference-Cited by-同舟云学术

Sirolimus for the treatment of juvenile nasopharyngeal angiofibroma

Published:2020-01-11 Issue:4 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Fernández Karen S.¹^ORCID,Alarcon Alessandro²,Adams Denise M.³^ORCID,Hammill Adrienne M.⁴^ORCID

Affiliation:

1. Solid Tumor ProgramValley Children's HospitalCancer and Blood Disorders CenterStanford University Madera California

2. Cincinnati Children's Hospital Medical CenterDivision of Pediatric Otolaryngology – Head and Neck SurgeryCenter for Pediatric Voice DisordersUniversity of Cincinnati Cincinnati Ohio

3. Boston Children's HospitalDivision of Hematology/OncologyVascular Anomalies Center (VAC), Harvard Medical School Boston Massachusetts

4. Cincinnati Children's Hospital Medical CenterCancer and Blood Diseases Institute, Hemangioma and Vascular Malformations CenterUniversity of Cincinnati Cincinnati Ohio

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28162

Reference27 articles.

1. Nasopharyngeal Angiofibromas: Staging and Management

2. Juvenile Nasopharyngeal Angiofibroma: Stage and Surgical Approach

3. Dysregulation of the TSC-mTOR pathway in human disease

4. Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis

5. AKT1 Overexpression in Endothelial Cells Leads to the Development of Cutaneous Vascular Malformations In Vivo

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct tumoral puncture embolization of onyx before endoscopic endonasal resection of a massive juvenile angiofibroma for a patient with Von Willebrand disease – A case report and review of literature;International Journal of Surgery Case Reports;2024-07

2. Neoadjuvant therapy of juvenile angiofibroma of the nasopharynx and base of the skull with good clinical outcome (clinical case);Head and Neck Tumors (HNT);2024-06-28

3. Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors;Current Oncology Reports;2024-02-20

4. FGFR3 and FGFR4 overexpression in juvenile nasopharyngeal angiofibroma: impact of smoking history and implications for personalized management;Journal of Applied Genetics;2023-09-01

5. Benign Paranasal Sinus Tumors;Current Otorhinolaryngology Reports;2023-07-05